0001140361-23-029698.txt : 20230613
0001140361-23-029698.hdr.sgml : 20230613
20230613195441
ACCESSION NUMBER: 0001140361-23-029698
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230608
FILED AS OF DATE: 20230613
DATE AS OF CHANGE: 20230613
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Smith David V
CENTRAL INDEX KEY: 0001229447
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41008
FILM NUMBER: 231012666
MAIL ADDRESS:
STREET 1: 6035 STONERIDGE DRIVE
CITY: PLEASANTON
STATE: CA
ZIP: 94588
FORMER NAME:
FORMER CONFORMED NAME: SMITH DAVID V
DATE OF NAME CHANGE: 20030429
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IO Biotech, Inc.
CENTRAL INDEX KEY: 0001865494
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 870909276
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: OLE MAALOES VEH 3
CITY: COPENHAGEN
STATE: G7
ZIP: 2200
BUSINESS PHONE: 4570702980
MAIL ADDRESS:
STREET 1: OLE MAALOES VEH 3
CITY: COPENHAGEN
STATE: G7
ZIP: 2200
4
1
form4.xml
X0407
4
2023-06-08
0001865494
IO Biotech, Inc.
IOBT
0001229447
Smith David V
C/O IO BIOTECH, INC.
OLE MAALOES VEJ 3
COPENHAGEN
G7
2200
DENMARK
true
false
Stock Option (Right to Buy)
2.075
2023-06-08
4
A
0
41533
0
A
2033-06-08
Common Stock
41533
41533
D
These options vest on June 8, 2024, subject to the reporting person's continued service through the applicable vesting date, and subject to 100% acceleration upon a change of control.
/s/ Brian Burkavage, Attorney-in-Fact for David V. Smith
2023-06-13